Biliopancreatic Diversion with Duodenal Switch in Patients with Type 2 Diabetes mellitus: Is the Chance of Complete Remission Dependent on Therapy and Duration of Insulin Treatment?

被引:9
|
作者
Cho, Eun-Young [1 ]
Kemmet, Olga [1 ]
Frenken, Michael [1 ]
机构
[1] St Josef Krankenhaus Monheim, Dept Surg, D-40789 Monheim, Germany
关键词
Biliopancreatic diversion with duodenal switch; BPD-DS; Type 2 diabetes mellitus; Complete remission; Insulin; OBESE-PATIENTS; SENSITIVITY; GLUCOSE; RESISTANCE; SURGERY; TERM;
D O I
10.1159/000327037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Rapid resolution of type 2 diabetes mellitus (T2DM) is a common feature after intestinal bypass surgery bypassing the duodenum and parts of the jejunum. However, the parameters determining the individual chance of remission are imprecisely defined. Methods: Biliopancreatic diversion with duodenal switch and sleeve gastrectomy (BPD-DS) was performed in n = 86 patients with T2DM (mean age 50 years, range 26-68, 51 females; BMI 47 kg/m(2), range 26-71). The patients were retrospectively divided into 4 groups according to the treatment modality and the duration of insulin treatment preoperatively: n = 18 patients were treated with oral antidiabetic drugs only (group 1); n = 32, n = 24, and n = 12 patients were treated with insulin for less than 5 years, for 5-10 years, and for more than 10 years (groups 2, 3, and 4), respectively. Results: At discharge from hospital, all patients of groups 1 and 2 were free of insulin usage, 30% and 75% of the patients of groups 3 and 4 used up to 48 units of insulin per day (mean 24, n = 16). After 1 year, only 4 patients of group 4 permanently required small amounts of insulin (mean 17 units per day) to keep blood glucose below 200 mg/dl. These 4 patients had been using insulin preoperatively for 13, 15, 22, and 25 years. In 3 of these 4 patients, fasting C-peptide was measured and found to be low (<1.2 ng/ml). The rate of complete remission of diabetes for the whole study population was 91%. Conclusion: BPD-DS reliably causes rapid and complete remission of T2DM in all patients on oral antidiabetic drugs and in patients with insulin treatment for less than 5 years. In patients with insulin treatment longer than 5 or 10 years, complete remission rates decline to 88 and 66%, respectively. A low C-peptide preoperatively might be a specific adverse prognostic parameter for the chance of diabetes remission.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [1] Long-term Remission of Type 2 Diabetes and Patient Survival After Biliopancreatic Diversion with Duodenal Switch
    Frenken, Michael
    Kemmet, Olga
    Frenken, Miriam
    Roehrig, Ingo
    Fischer, Lars
    Hellinger, Achim
    OBESITY SURGERY, 2022, 32 (10) : 3340 - 3350
  • [2] Long-term Remission of Type 2 Diabetes and Patient Survival After Biliopancreatic Diversion with Duodenal Switch
    Michael Frenken
    Olga Kemmet
    Miriam Frenken
    Ingo Röhrig
    Lars Fischer
    Achim Hellinger
    Obesity Surgery, 2022, 32 : 3340 - 3350
  • [3] Ten-year remission rates in insulin-treated type 2 diabetes after biliopancreatic diversion with duodenal switch
    Kapeluto, Jordanna E.
    Tchernof, Andre
    Masckauchan, Daiana
    Biron, Simon
    Marceau, Simon
    Hould, Frederic-Simon
    Lebel, Stefane
    Lescelleur, Odette
    Julien, Francois
    Biertho, Laurent
    SURGERY FOR OBESITY AND RELATED DISEASES, 2020, 16 (11) : 1701 - 1712
  • [4] Long-term glycemic control after sleeve gastrectomy and biliopancreatic diversion with duodenal switch in patients with type 2 diabetes mellitus
    Gamlestol, Randi S.
    Andersen, John R.
    Vage, Villy
    SCANDINAVIAN JOURNAL OF SURGERY, 2025,
  • [5] Insulin action in subjects with type 2 diabetes following biliopancreatic diversion
    Papadia, Francesco
    Carlini, Flavia
    Rubartelli, Alice
    Battistini, Micaela
    Cordera, Renzo
    Adami, Gian Franco
    Camerini, Giovanni
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (04)
  • [6] Barriers to insulin treatment in patients with type 2 diabetes mellitus
    Tziomalos, Konstantinos
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (03) : 233 - 234
  • [7] Insulin therapy in patients with type 2 diabetes mellitus
    Odeniyi, Ifedayo Adeola
    Olopade, Oluwarotimi Bolaji
    Fasanmade, Olufemi Adetola
    JOURNAL OF CLINICAL SCIENCES, 2019, 16 (02) : 43 - 48
  • [8] Intensifying insulin therapy in patients with type 2 diabetes mellitus
    Hirsch, IB
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 : 21 - 26
  • [9] Biliopancreatic diversion with duodenal switch leads to better postprandial glucose level and beta cell function than sleeve gastrectomy in individuals with type 2 diabetes very early after surgery
    Michaud, Andreanne
    Grenier-Larouche, Thomas
    Caron-Dorual, Dominique
    Marceau, Simon
    Biertho, Laurent
    Simard, Serge
    Richard, Denis
    Tchernof, Andre
    Carpentier, Andre C.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 74 : 10 - 21
  • [10] High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion
    Bonaventura, A.
    Liberale, L.
    Carbone, F.
    Scopinaro, N.
    Camerini, G.
    Papadia, F. S.
    Cordera, R.
    Dallegri, F.
    Adami, G. F.
    Montecucco, F.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2017, 27 (05) : 423 - 429